INSM(INSM)
INSM
Q4 2026 EPS Estimate
$-0.37
Oct 29, 2026 · Reports before open
Revenue Estimate
$501M
FY2027E EPS$0.33
FY2028E EPS$3.12
Analyst Sentiment
Wall St. Consensus
Buy28 analysts·High coverage
74
Score
27 Buy (96%)1 Hold (4%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2796%
Hold
14%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$169.00
+32.2%
Consensus
$197.50
+54.5%
Bull
$235.00
+83.8%
12-Month Target Range28 analysts
$169.00$197.50$235.00
Current $127.87Consensus
Current Price
$127.87
Upside to Consensus
$69.63
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+62.89%
EPS—
FY2028
Rev+36.43%
EPS+838.69%
FY2029
Rev+30.88%
EPS+115.56%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.70B | $2.77B | $3.78B | $4.95B | $6.27B |
| Low | $1.65B | $2.45B | $2.77B | $4.22B | $5.35B |
| High | $1.74B | $3.04B | $4.69B | $5.59B | $7.09B |
| EBITDA Avg | $-1.70B | $-2.77B | $-3.78B | $-4.95B | $-6.27B |
| Low | $-1.74B | $-3.04B | $-4.69B | $-5.59B | $-7.09B |
| High | $-1.65B | $-2.45B | $-2.77B | $-4.22B | $-5.35B |
| EBIT Avg | $-1.70B | $-2.77B | $-3.78B | $-4.95B | $-6.27B |
| Low | $-1.74B | $-3.04B | $-4.69B | $-5.59B | $-7.09B |
| High | $-1.65B | $-2.45B | $-2.77B | $-4.22B | $-5.35B |
| Net Income Avg | $-566M | $25M | $594M | $1.44B | $2.18B |
| Low | $-741M | $-279M | $-159M | $1.16B | $1.76B |
| High | $-367M | $276M | $1.43B | $1.68B | $2.55B |
| EPS Avg | $-2.61 | $0.33 | $3.12 | $6.73 | $10.21 |
| Low | $-3.47 | $-1.31 | $-0.74 | $5.45 | $8.26 |
| High | $-1.72 | $1.29 | $6.67 | $7.87 | $11.93 |
| Analysts (Rev / EPS) | 16 / 16 | 16 / 16 | 19 / 18 | 9 / 9 | 15 / 8 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $467M | $532M | $561M | $641M | $710M | $766M | $771M | $838M |
| Low | $444M | $441M | $501M | $573M | $633M | $684M | $689M | $748M |
| High | $480M | $595M | $599M | $685M | $757M | $818M | $823M | $894M |
| EBITDA Avg | $-467M | $-532M | $-561M | $-641M | $-710M | $-766M | $-771M | $-838M |
| Low | $-480M | $-595M | $-599M | $-685M | $-757M | $-818M | $-823M | $-894M |
| High | $-444M | $-441M | $-501M | $-573M | $-633M | $-684M | $-689M | $-748M |
| EBIT Avg | $-467M | $-532M | $-561M | $-641M | $-710M | $-766M | $-771M | $-838M |
| Low | $-480M | $-595M | $-599M | $-685M | $-757M | $-818M | $-823M | $-894M |
| High | $-444M | $-441M | $-501M | $-573M | $-633M | $-684M | $-689M | $-748M |
| Net Income Avg | $-130M | $-115M | $-48M | $-7M | $19M | $44M | $121M | $159M |
| Low | $-205M | $-423M | $-53M | $-8M | $16M | $38M | $104M | $137M |
| High | $-75M | $131M | $-42M | $-6M | $20M | $48M | $131M | $173M |
| EPS Avg | $-0.60 | $-0.53 | $-0.22 | $-0.03 | $0.09 | $0.20 | $0.56 | $0.73 |
| Low | $-0.94 | $-1.95 | $-0.24 | $-0.04 | $0.07 | $0.18 | $0.48 | $0.63 |
| High | $-0.35 | $0.60 | $-0.19 | $-0.03 | $0.09 | $0.22 | $0.60 | $0.80 |
| Analysts (Rev / EPS) | 13 / 12 | 18 / 16 | 9 / 8 | 9 / 7 | 13 / 7 | 9 / 12 | 16 / 9 | 10 / 8 |